NasdaqCM:BHTG

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions for the control, reduction, and/or reuse of organic and municipal waste worldwide.


Snowflake Analysis

Limited growth with worrying balance sheet.


Similar Companies

Share Price & News

How has BioHiTech Global's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: BHTG's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-6.3%

BHTG

3.1%

US Commercial Services

-0.04%

US Market


1 Year Return

-25.3%

BHTG

9.4%

US Commercial Services

17.1%

US Market

Return vs Industry: BHTG underperformed the US Commercial Services industry which returned 8.3% over the past year.

Return vs Market: BHTG underperformed the US Market which returned 16.8% over the past year.


Shareholder returns

BHTGIndustryMarket
7 Day-6.3%3.1%-0.04%
30 Day-6.3%14.4%5.1%
90 Day36.4%24.6%19.5%
1 Year-25.3%-25.3%11.1%9.4%19.6%17.1%
3 Year-75.0%-75.0%52.9%43.1%42.5%33.3%
5 Yearn/a92.5%73.0%75.1%56.2%

Price Volatility Vs. Market

How volatile is BioHiTech Global's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is BioHiTech Global undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether BioHiTech Global is trading at an attractive price based on the cash flow it is expected to produce in the future. But as BioHiTech Global has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is BioHiTech Global forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

81.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: BHTG is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BHTG is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BHTG is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: BHTG's revenue (44.5% per year) is forecast to grow faster than the US market (9.4% per year).

High Growth Revenue: BHTG's revenue (44.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if BHTG's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has BioHiTech Global performed over the past 5 years?

-18.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: BHTG is currently unprofitable.

Growing Profit Margin: BHTG is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: BHTG is unprofitable, and losses have increased over the past 5 years at a rate of 18.6% per year.

Accelerating Growth: Unable to compare BHTG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: BHTG is unprofitable, making it difficult to compare its past year earnings growth to the Commercial Services industry (-6.5%).


Return on Equity

High ROE: BHTG has a negative Return on Equity (-175.2%), as it is currently unprofitable.


Next Steps

Financial Health

How is BioHiTech Global's financial position?


Financial Position Analysis

Short Term Liabilities: BHTG's short term assets ($6.1M) do not cover its short term liabilities ($18.0M).

Long Term Liabilities: BHTG's short term assets ($6.1M) do not cover its long term liabilities ($31.8M).


Debt to Equity History and Analysis

Debt Level: BHTG's debt to equity ratio (605.6%) is considered high.

Reducing Debt: BHTG had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BHTG has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: BHTG has less than a year of cash runway if free cash flow continues to reduce at historical rates of 28.7% each year


Next Steps

Dividend

What is BioHiTech Global current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate BHTG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate BHTG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if BHTG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if BHTG's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of BHTG's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.5yrs

Average management tenure


CEO

Frank Celli (50 yo)

5yrs

Tenure

US$300,000

Compensation

Mr. Frank E. Celli has been the Chief Executive Officer of BioHiTech Global, Inc. since August 06, 2015 and serves as its Chairman of the Board. Mr. Celli joined BioHiTech America in 2008. Mr. Celli serves ...


CEO Compensation Analysis

Compensation vs Market: Frank's total compensation ($USD300.00K) is below average for companies of similar size in the US market ($USD589.17K).

Compensation vs Earnings: Frank's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Frank Celli
Chairman & CEO5yrsUS$300.00k10.59%
$ 3.9m
Robert Joyce
Chief Operating Officer2.58yrsUS$265.00k1.51%
$ 562.1k
Brian Essman
Chief Financial Officer4.75yrsUS$210.00k0.45%
$ 169.1k
Anthony Fuller
Chief Administrative Officer & Director3.5yrsno data0.022%
$ 8.3k
Lisa Giovannielli
Marketing Directorno datano datano data
Michael Franco
Vice President of Salesno datano datano data
Dennis Soriano
Director of Business Development and Strategic Relationships4.42yrsno datano data
Richard Galterio
Executive Vice Presidentno datano datano data
Michael Schmidt
Executive Vice President of Strategic Growth & Initiatives1yrno datano data

3.5yrs

Average Tenure

61yo

Average Age

Experienced Management: BHTG's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Celli
Chairman & CEO5yrsUS$300.00k10.59%
$ 3.9m
Anthony Fuller
Chief Administrative Officer & Director3.5yrsno data0.022%
$ 8.3k
Douglas VanOort
Independent Director5yrsno datano data
Harriet Hentges
Independent Director5yrsno data0.0089%
$ 3.3k
James Chambers
Independent Director12.08yrsno data0.65%
$ 242.3k
Robert Graham
Independent Director6.83yrsno datano data
Nicholaus Rohleder
Independent Director0.17yrno datano data
Walter Littlejohn
Independent Director0.083yrno datano data

5.0yrs

Average Tenure

62.5yo

Average Age

Experienced Board: BHTG's board of directors are considered experienced (5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: BHTG insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 51.4%.


Top Shareholders

Company Information

BioHiTech Global, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: BioHiTech Global, Inc.
  • Ticker: BHTG
  • Exchange: NasdaqCM
  • Founded:
  • Industry: Environmental and Facilities Services
  • Sector: Commercial Services
  • Market Cap: US$37.252m
  • Shares outstanding: 22.58m
  • Website: https://www.biohitech.com

Number of Employees


Location

  • BioHiTech Global, Inc.
  • 80 Red Schoolhouse Road
  • Suite 101
  • Chestnut Ridge
  • New York
  • 10977
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BHTGNasdaqCM (Nasdaq Capital Market)YesCommon SharesUSUSDAug 2015
46QDB (Deutsche Boerse AG)YesCommon SharesDEEURAug 2015

Biography

BioHiTech Global, Inc., through its subsidiaries, provides technological, biological, and mechanical engineering solutions for the control, reduction, and/or reuse of organic and municipal waste worldwide. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/12 00:02
End of Day Share Price2020/08/11 00:00
Earnings2020/03/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.